Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Akari Therapeutics Plc (AKTX) Institutional Ownership & Insider Trading

9 institutions reported holding Akari Therapeutics Plc shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

AKTXAkari Therapeutics PlcFollow AKTX — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
640.6M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

9 institutions held 0.0% of the shares. Across filers that reported both quarters, shares held changed —.

Increased+1New+5Decreased+0Closed-2

Largest moves, shares (millions)

MMCAP International Inc. SPC+0.1MJane Street Group+0.0MHrt Financial+0.0MArmistice Capital-0.0MMorgan Stanley-0.0M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Sep 24+0.1Dec 24-0.0Mar 25+0.2Jun 25+0.6Sep 25+3.2Dec 25+0.0Mar 26+0.1Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2690—1502
Mar 2660—————
Dec 25214+272.9%3714
Sep 25151+112.5%1332
Jun 25151+80.9%0531
Mar 25110-1.7%0113
Dec 24140+78.0%1411
Sep 24100+0.6%1112

Akari Therapeutics Plc — questions

Who owns Akari Therapeutics Plc stock?
9 institutions reported Akari Therapeutics Plc shares in 13F filings for the quarter ended 2026-06-30. The largest: MMCAP International Inc. SPC (0.0%), Cresset Asset Management, LLC (0.0%), JANE STREET GROUP, LLC (0.0%).

Every figure on this page comes from Akari Therapeutics Plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.